Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

The patients with non-valvular atrial fibrillation (NVAF), both permanent and paroxysmal, and history of previous transient ischemic attack (TIA) or stroke represent a category of patients at high risk of new embolic events, independently of the presence of other risk factors. In these patients, nat...

Full description

Bibliographic Details
Main Authors:	Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-12-01
Series:	Italian Journal of Medicine
Subjects:	atrial fibrillation, warfarin, stroke, prophylaxis, dabigatran, rivaroxaban, apixaban.
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/110

Similar Items

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows
by: Luca Masotti, et al.
Published: (2012-10-01)

The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy
by: Luca Masotti, et al.
Published: (2013-12-01)

Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?
by: Luca Masotti, et al.
Published: (2019-01-01)

A Combination of Ex Vivo and In Vivo Strategies for Evaluating How Much New Oral Anticoagulants Exacerbate Experimental Intracerebral Bleeding
by: Ferreira Ferreira, et al.
Published: (2023-07-01)

Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
by: Hallinen T, et al.
Published: (2021-08-01)

IMPACT OF NON-VITAMIN K ORAL ANTI-COAGULANTS ON WARFARIN UTILISATION AND NHS BUDGET IN UK
by: Mohammed Aladul, et al.
Published: (2022-09-01)

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
by: Woldesellassie M. Bezabhe, et al.
Published: (2022-10-01)

The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
by: Brendan Wood, et al.
Published: (2017-08-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists
by: Giancarlo Landini, et al.
Published: (2013-12-01)

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
by: Tommaso Sacquegna, et al.
Published: (2015-12-01)

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
by: Paolo Zappulla, et al.
Published: (2021-04-01)

Management of Patients Using Oral Anticoagulant Agent in Dental Practice
by: Özge DOĞANAY, et al.
Published: (2019-07-01)

Are outpatient anticoagulation management services the wave of the future (again)?
by: Bethany Samuelson Bannow
Published: (2022-05-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
by: Sergey N. Bel'diev, et al.
Published: (2019-05-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
by: S. N. Bel'diev, et al.
Published: (2019-05-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
by: Sergey N. Bel'diev, et al.
Published: (2019-05-01)

A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01)

New oral anticoagulants and cardiac safety: do we have a problem?
by: E. M. Nifontov
Published: (2018-04-01)

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
by: Martina Mookadam, et al.
Published: (2015-01-01)

Practical issues in measuring the anticoagulant effect of direct oral anticoagulants
by: Dopsaj Violeta
Published: (2020-01-01)

The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants
by: Jamshed Dalal, et al.
Published: (2015-12-01)

Pharmacogenetics of new oral anticoagulants
by: Bella A. Azimova, et al.
Published: (2023-04-01)

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions
by: V. A. Ionin, et al.
Published: (2021-05-01)

DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS
by: S. N. Bel'diev, et al.
Published: (2017-11-01)

Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
by: Ju Yup Lee
Published: (2018-12-01)

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
by: Sergey Nikolaevich Bel'diev, et al.
Published: (2017-11-01)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
by: Natalia A. Shnayder, et al.
Published: (2021-04-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
by: Sergey Nikolaevich Bel'diev, et al.
Published: (2017-11-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation
by: N. Z. Gasymova, et al.
Published: (2019-05-01)

DENTAL IMPLICATIONS OF THE NEW ORAL ANTICOAGULANTS
by: Cringuta Paraschiv, et al.
Published: (2016-01-01)

Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
by: Ramin Artang, et al.
Published: (2019-07-01)

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis
by: Mauro Silingardi
Published: (2013-12-01)

Assessment and predictors of inappropriate dose of direct oral anticoagulants
by: Mosaad O. Almegren
Published: (2024-01-01)

Direct oral anticoagulants; a review for the non-specialist
by: Thilina Gunawardena
Published: (2021-11-01)